Oncostatin M receptor-dependent signaling assessed by RNA sequencing in mouse hematopoietic stem cells

Sci Data. 2024 Sep 12;11(1):996. doi: 10.1038/s41597-024-03839-3.

Abstract

Oncostatin M (OSM) is a member of the interleukin-6 (IL-6) family of cytokines and has been found to have anti-inflammatory and pro-inflammatory properties in various cellular and disease contexts. OSM signals through two receptor complexes, one of which includes OSMRβ. Here, we investigated OSM-OSMRβ signaling in adult mouse hematopoietic stem cells (HSCs) using the conditional Osmrfl/fl mouse model B6;129-Osmrtm1.1Nat/J. We crossed Osmrfl/fl mice to interferon-inducible Mx1-Cre, which is robustly induced in adult HSCs. From these mice, we isolated HSCs by flow cytometry, stimulated with recombinant OSM or vehicle for 1 hour, and assessed gene expression changes in control versus Osmr knockout HSCs by RNA-seq. This data may be utilized to investigate OSMRβ -dependent and -independent OSM signaling as well as the transcriptional effects of an IL-6 family cytokine on mouse HSCs to further define its anti-inflammatory versus pro-inflammatory properties.

Publication types

  • Dataset

MeSH terms

  • Animals
  • Hematopoietic Stem Cells* / drug effects
  • Hematopoietic Stem Cells* / metabolism
  • Mice
  • Oncostatin M Receptor beta Subunit / genetics
  • Oncostatin M* / pharmacology
  • RNA-Seq
  • Receptors, Oncostatin M / genetics
  • Sequence Analysis, RNA
  • Signal Transduction*

Substances

  • Oncostatin M
  • Oncostatin M Receptor beta Subunit
  • Receptors, Oncostatin M